IPO Story

Email this story | Print Story

Stereotaxis Cuts IPO Ahead of Pricing

Jeffrey R. Hirschkorn, Senior IPO Analyst, Aug. 11, 2004

In an attempt to get its IPO done in a tough climate for new stock issuance, Stereotaxis (proposed: STXS), a medical technology firm, announced revisions to its IPO prior to pricing. New offering structure anticipated the pricing of five million shares at talk of $8-$10. That is a drastic hair cut from original goals of 6.5 million shares at $14-$16. Goldman Sachs and Bear Stearns are joint book runners on the IPO.

Final terms for pricing: five million shares at $8. Trading to begin on Thursday.

Email this story | Print Story